drugset / Trial / NCT05567094

The Effect of Perioperative DEXamethasone on Postoperative Complications After PANcreaticoduodenectomy

NCT05567094 ↗

Phase 4 Completed 300 enrolled Ruijin Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary objective of this clinical trial is evaluate the effect of dexamethasone on postoperative complications after pancreaticoduodenectomy.

Timeline

Start
2022-10-08
Primary completion
2023-09-14
Completion
2023-09-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.2 mg/kg Intravenous

Indications

No indication recorded.